Josephine Ford Cancer Center at Henry Ford Hospital
Claim this profileSummary
Josephine Ford Cancer Center at Henry Ford Hospital is a medical facility located in Detroit, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Brain Tumor, Central Nervous System Tumor, Glioblastoma and other specialties. Josephine Ford Cancer Center at Henry Ford Hospital is involved with conducting 175 clinical trials across 203 conditions. There are 9 research doctors associated with this hospital, such as Ding Wang, Shirish Gadgeel, MD, Tobias Walbert, MD, PhD, MPH, and Philip Kuriakose, MD.Area of expertise
Lung Cancer
Josephine Ford Cancer Center at Henry Ford Hospital has run 37 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Josephine Ford Cancer Center at Henry Ford Hospital has run 32 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Ding Wang
Henry Ford Hospital
6 years of reported clinical research
Shirish Gadgeel, MD
Henry Ford Hospital
4 years of reported clinical research
Tobias Walbert, MD, PhD, MPH
Henry Ford Hospital
7 years of reported clinical research
Philip Kuriakose, MD
Henry Ford Health System
5 years of reported clinical research
Clinical Trials running at Josephine Ford Cancer Center at Henry Ford Hospital
Breast Cancer
Lung Cancer
Cancer
Acute Myeloid Leukemia
Leukemia
Acute Myelogenous Leukemia
Solid Tumors
Non-Small Cell Lung Cancer
Metastatic Tumor
Pancreatic Cancer
Endoxifen
for Breast Cancer
This trial is testing (Z)-endoxifen, a drug that blocks estrogen, in pre-menopausal women with a specific type of breast cancer. The study aims to see if this drug can slow down cancer growth by measuring a marker called Ki-67. Participants will take the drug daily for several months before surgery.
Recruiting
1 award
Phase 2
7 criteria
IAM1363
for Breast Cancer
This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 in participants with advanced cancers that harbor HER2 alterations.
Recruiting
1 award
Phase 1
MRT-2359
for Solid Tumors
This trial tests a new drug called MRT-2359 that breaks down a protein in cancer cells. It targets patients with certain types of previously treated cancers. The drug aims to destroy a protein crucial for cancer cell survival, potentially stopping or slowing the cancer.
Recruiting
1 award
Phase 1 & 2
7 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Josephine Ford Cancer Center at Henry Ford Hospital?
Josephine Ford Cancer Center at Henry Ford Hospital is a medical facility located in Detroit, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Brain Tumor, Central Nervous System Tumor, Glioblastoma and other specialties. Josephine Ford Cancer Center at Henry Ford Hospital is involved with conducting 175 clinical trials across 203 conditions. There are 9 research doctors associated with this hospital, such as Ding Wang, Shirish Gadgeel, MD, Tobias Walbert, MD, PhD, MPH, and Philip Kuriakose, MD.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.